KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

BioNTech SE (BNTX) Return on Sales (2018 - 2025)

Historic Return on Sales for BioNTech SE (BNTX) over the last 8 years, with Q3 2025 value amounting to 0.05%.

  • BioNTech SE's Return on Sales fell 1100.0% to 0.05% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.17%, marking a year-over-year decrease of 1500.0%. This contributed to the annual value of 0.25% for FY2024, which is 6300.0% down from last year.
  • According to the latest figures from Q3 2025, BioNTech SE's Return on Sales is 0.05%, which was down 1100.0% from 1.61% recorded in Q2 2025.
  • In the past 5 years, BioNTech SE's Return on Sales ranged from a high of 1.13% in Q4 2021 and a low of 6.25% during Q2 2024
  • For the 5-year period, BioNTech SE's Return on Sales averaged around 0.27%, with its median value being 0.24% (2021).
  • In the last 5 years, BioNTech SE's Return on Sales crashed by -51100bps in 2024 and then soared by 46400bps in 2025.
  • Over the past 5 years, BioNTech SE's Return on Sales (Quarter) stood at 1.13% in 2021, then plummeted by -53bps to 0.53% in 2022, then increased by 10bps to 0.59% in 2023, then tumbled by -63bps to 0.22% in 2024, then plummeted by -76bps to 0.05% in 2025.
  • Its last three reported values are 0.05% in Q3 2025, 1.61% for Q2 2025, and 2.6% during Q1 2025.